Acute IL-4 Governs Pathogenic T Cell Responses during Leishmania major Infection.

Area of Science:

• Immunology
• Parasitology
• Infectious Diseases

Background:

• Leishmania spp. infection poses a significant global health challenge, impacting millions worldwide.
• Immune responses, particularly T helper 1 (Th1) and T helper 2 (Th2), critically influence Leishmania infection outcomes.
• Interleukin-4 (IL-4), a hallmark Th2 cytokine, is implicated in susceptibility to Leishmania major infection.

Purpose of the Study:

• To investigate the cellular and molecular mechanisms regulated by IL-4 signaling during Leishmania major infection.
• To elucidate the role of early IL-4 exposure in shaping both Th1 and Th2 immune responses.
• To determine the impact of IL-4 on CD4+ and CD8+ T cell responses and their contribution to disease pathology.

Main Methods:

• Utilized IL-4-neutralizing antibodies in a mouse model of Leishmania major infection (BALB/c strain).
• Performed temporal neutralization of IL-4 to assess the impact of early versus late signaling.
• Analyzed T cell responses, including interferon-gamma (IFN-γ) and T-box transcription factor (Tbet) expression, in CD4+ and CD8+ T cells.

Main Results:

• Neutralization of IL-4 conferred protection against Leishmania major infection, consistent with previous findings.
• Early IL-4 exposure was crucial for programming IL-4-producing Th2 CD4+ T cells and promoting IFN-γ production by CD8+ T cells.
• IL-4 signaling enhanced anti-CD3-induced Tbet and IFN-γ expression in both CD4+ and CD8+ T cells, suggesting a dual role.

Conclusions:

• IL-4 plays a complex role in Leishmania major infection, promoting susceptibility via Th2 responses and exacerbating pathology through pathogenic CD8+ T cell responses.
• Early IL-4 signaling is critical for the development of both Th2 and pathogenic CD8+ T cell immunity.
• These findings highlight a previously unsuspected role for IL-4 in regulating both Th1 and Th2 immune responses, opening new avenues for research.